Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL.
| Image |  |
|---|---|
| Description | scientific article published on 2 April 2019 |
| Author/s |
author: Mark Geyer |
| Publication date | April 2, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |